Stock Track | Pharming Group Plunges 17.32% in Pre-Market After Q1 Earnings and Revenue Miss Estimates
Stock Track
May 07
Pharming Group N.V. (PHAR) experienced a significant pre-market plunge of 17.32% on Thursday, following the release of its first-quarter financial results.
The sharp decline was driven by the company's Q1 earnings and revenue falling short of analyst expectations. Pharming reported a quarterly loss per share, missing consensus estimates that had anticipated a profit. Revenue for the quarter also came in significantly below forecasts, showing a year-over-year decrease.
While the company maintained its full-year revenue guidance, the substantial miss on both earnings and revenue metrics for Q1 appears to have triggered negative investor sentiment and the subsequent sell-off in the stock during pre-market trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.